Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT06717685
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 210 participants
- Sponsor
- Rashid Latif Medical College
- Registry
-
NCT06717685
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT06717685. Randomized; single masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2025-01-27 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
- Condition
- Supraventricular Tachycardia (SVtach)
- Intervention (Drug)
- Adenosine
- Intervention (Drug)
- Verapamil Injection
- Lead sponsor
- Rashid Latif Medical College
- Collaborator
- Punjab Institute of Cardology
- Collaborator
- Himmel Pharmaceutical private limited, Pakistan
Record details
- Record id
cardio:ct-nct06717685- Content hash
cf438be03beac23d0c445a655e3d9a9961a1c80e8793f84209071e9c81415f30